Aurobindo Pharma Ltd

NSE: AUROPHARMA BSE: 524804

₹1713.40

(1.19%)

Tue, 22 Sept 2026, 06:16 pm

MTF 5xInvest in Aurobindo Pharma Ltd with 5x Leverage Buy with MTF

Market Cap (in Cr)99828.06

PE Ratio26.77

Dividend0.23

Health Technology

Pharmaceuticals: Other

24.5K

Aurobindo Pharma News

Aurobindo Pharma to host JP Morgan analyst meet

Aurobindo Pharma officials will participate in a group investor meeting with JP Morgan on September 24, 2026, in Hyderabad. No UPSI will be discussed.

21 Sept 2026

companies

Aurobindo Pharma gets USFDA nod for Beclomethasone HFA

Aurobindo Pharma secured USFDA final approval for Beclomethasone Dipropionate HFA Inhalation Aerosol in 40 mcg and 80 mcg strengths, its first MDI product, in a US market worth $301 million.

15 Sept 2026

companies

Aurobindo Pharma acquires A1 Biochem USA stake

Aurobindo Pharma completes acquisition of 100% stake in newly incorporated A1 Biochem USA Inc for $1 million to expand CRO services.

12 Sept 2026

companies

Aurobindo Pharma unit clears US FDA inspection cleanly

Aurobindo Pharma's subsidiary Apitoria's Unit-IV API facility completed a US FDA inspection with no observations or issues raised, signalling regulatory compliance.

11 Sept 2026

companies

Aurobindo Pharma to attend Bank of America Asia Pacific conference

Aurobindo Pharma officials will participate in the Bank of America 2026 Asia Pacific Conference in Hong Kong on September 21, 2026. The company confirmed that no unpublished price-sensitive information will be discussed during the scheduled one-on-one and group meetings.

11 Sept 2026

companies

Showing 1–5 of 154

Rows per page:

Market Current News

US imposes visa curbs on 32 Prince Group TCO-linked individuals

The US State Department has imposed visa restrictions on 32 individuals linked to the Prince Group transnational criminal organisation, signalling a firm enforcement stance.

21 Sept 2026

global

Unitec Fibres IPO DRHP: Key Dates & Risks

Unitec Fibres files DRHP for ₹31 Cr fresh issue to repay debt. IPO opens Sep 23, 2026. Key risks include regulatory lapses and single-product dependency.

21 Sept 2026

ipo

Liqvd Digital India IPO DRHP: ₹26.16 Cr Fresh Issue

Liqvd Digital India files DRHP for ₹26.16 crore fresh issue. The digital marketing agency reports FY26 revenue of ₹60.24 crore and plans to complete AdLift acquisition.

21 Sept 2026

ipo

Pooja Logistics IPO DRHP: ₹33.97 Cr for Fleet Expansion

Pooja Logistics files DRHP for SME IPO opening Sep 23, 2026. Revenue hit ₹165.70 Cr in FY26. Funds to buy 92 new refrigerated trucks. GST demand risk noted.

21 Sept 2026

ipo

Coreintegra IPO DRHP: ₹18.01 Cr Fresh Issue

Coreintegra Consulting Services files DRHP for ₹18.01 crore fresh issue. HR solutions provider reports FY26 revenue of ₹515.15 crore with 18.58% CAGR. IPO opens Sep 23.

21 Sept 2026

ipo

Showing 1–5 of 94320

Rows per page: